All too true BRR, with regards to sales. Management have talked to many KOL's and soon (3 - 6 months) we need to see a ROI that will suggest this is commercially viable. The last thing we want is for them to 'not' get a strangle hold on the Chronic Ulcer market and just dilly dally around with new products and or indications.
Only time will tell...
